These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J; Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356 [TBL] [Abstract][Full Text] [Related]
3. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ; Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971 [TBL] [Abstract][Full Text] [Related]
4. Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache. Limmroth V; Biondi D; Pfeil J; Schwalen S Headache; 2007 Jan; 47(1):13-21. PubMed ID: 17355489 [TBL] [Abstract][Full Text] [Related]
5. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures. Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543 [TBL] [Abstract][Full Text] [Related]
6. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Winner P; Pearlman EM; Linder SL; Jordan DM; Fisher AC; Hulihan J; Headache; 2005; 45(10):1304-12. PubMed ID: 16324162 [TBL] [Abstract][Full Text] [Related]
10. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine. Mei D; Ferraro D; Zelano G; Capuano A; Vollono C; Gabriele C; Di Trapani G Clin Neuropharmacol; 2006; 29(5):269-75. PubMed ID: 16960472 [TBL] [Abstract][Full Text] [Related]
11. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs. Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J; Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844 [TBL] [Abstract][Full Text] [Related]
12. The impact of topiramate on health-related quality of life indicators in chronic migraine. Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ Headache; 2007; 47(10):1398-408. PubMed ID: 18052949 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment. Brown JS; Papadopoulos G; Neumann PJ; Friedman M; Miller JD; Menzin J Headache; 2005 Sep; 45(8):1012-22. PubMed ID: 16109115 [TBL] [Abstract][Full Text] [Related]
14. Topiramate in migraine prevention: evidence-based medicine from clinical trials. Silberstein SD Neurol Sci; 2004 Oct; 25 Suppl 3():S244-5. PubMed ID: 15549548 [TBL] [Abstract][Full Text] [Related]
15. Topiramate in migraine prevention: results of a large controlled trial. Silberstein SD; Neto W; Schmitt J; Jacobs D; Arch Neurol; 2004 Apr; 61(4):490-5. PubMed ID: 15096395 [TBL] [Abstract][Full Text] [Related]
16. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications. Cady RK; Voirin J; Farmer K; Browning R; Beach ME; Tarrasch J Headache; 2012 May; 52(5):749-64. PubMed ID: 22188311 [TBL] [Abstract][Full Text] [Related]
17. Topiramate for migraine prevention in a naturalistic setting: results from an open label, flexible dose study. Nelles G; Delbrück A; Schulze L; Kademann B; Bornhoevd K; Schäfer S; Schäuble B; Headache; 2009; 49(10):1454-65. PubMed ID: 19804392 [TBL] [Abstract][Full Text] [Related]
18. Antiepileptic drugs in the prophylaxis of migraine, chronic headache forms and cluster headache: a review of their efficacy and tolerability. D'Amico D Neurol Sci; 2007 May; 28 Suppl 2():S188-97. PubMed ID: 17508169 [TBL] [Abstract][Full Text] [Related]
19. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials. Bussone G; Diener HC; Pfeil J; Schwalen S Int J Clin Pract; 2005 Aug; 59(8):961-8. PubMed ID: 16033621 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of topiramate in the treatment of pediatric chronic daily headache. Borzy JC; Koch TK; Schimschock JR Pediatr Neurol; 2005 Nov; 33(5):314-6. PubMed ID: 16243217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]